Moreover, in CRC xenografts, PARP inhibition was demonstrated to increase the tumour growth delay effect of CRT (radiotherapy with either irinotecan, oxaliplatin, or 5-Fluorouracil) [110]. This evidence concerns the gene PARP1 and colorectal carcinoma.